echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Where will the future of the 23,000 private hospitals of "Pharmaceutical Headlines" go?

    Where will the future of the 23,000 private hospitals of "Pharmaceutical Headlines" go?

    • Last Update: 2020-10-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    (2020/10/10) Another Phase 3 clinical failure of Pfizer Ibrace's treatment of early breast cancer; NEJM's publication of the final results of the Redsiway global trial shows three important benefits; and forecasts of the current state of China's bio-innovative pharmaceutical industry and future market size... (Click on the title, available in the original article) "Pharmaceutical 1st Time" Pfizer Ibrance treatment of early breast cancer another Phase 3 clinical failure 9th, Pfizer announced that Ibrance in the treatment of HR/ HER2 - early breast cancer in the second large-scale phase 3 clinical study PENELOPE-B failure.
    The study, conducted in patients with HR-/HER2-early breast cancer with a high risk of recurrence after completion of new assisted chemotherapy and tumor excision, assessed the efficacy and safety of 1 year of Ibrace therapy combined with at least 5 years of standard assisted endocrine therapy and placebo combined with at least 5 years of standard assisted endocrine therapy.
    results show that the study did not reach the main endpoint of extending the survival of non-invasive disease (iDFS).
    : Pfizer's setback leaves Lilly Verzenio with a chance.
    the future of the 23,000 private hospitals will be cleaned up by the National Health and Health Commission? Recently, the National Health and Health Commission issued a "notice on the implementation of the "Private Hospital Management Year" activities.
    notice shows that from August this year to December 2022, various types of private hospitals at all levels to carry out "private hospital management year" activities, including regulating the practice of private hospitals, to ensure the quality of private hospitals and medical safety and other content.
    headlines: the negative news that private hospitals keep exposing.
    , NEJM published the final results of the Redsiway Global Trials, showing that three important benefits have gained sustained attention from the industry and the general public as the global epidemic progresses.
    comes after preliminary results from a global clinical trial called ACTT-1 sponsored by the American Institute of Allergy and Infectious Diseases (NIAID) showed that Redsyvir significantly accelerated the recovery time of patients hospitalized with neo-coronavirus disease (COVID-19).
    : Using antiviral drugs alone is not enough to treat all patients.
    Firestone Creation: China's bio-innovative pharmaceutical industry development status quo and future market size forecast in 1982, the FDA approved the first gene recombinant biological products, since then opened the beginning of biopharmaceuticals;
    : Bio-innovative drugs will become a must-win for biopharmaceutical companies.
    "Pharmaceutical Rubik's Cube" medicine tycoon's next ride on the fast train of the times, the domestic in recent years has also emerged a lot of like Fuhong Hanxuan, "the thorns, the future" of the pharmaceutical enterprises.
    the emergence of this situation can not be separated from the "talent" help, and with the acceleration of the development process of the industry, the flow of talent is more frequent.
    We've previously reported on the flow of talent in the pharmaceutical industry, from Wall Street investors to innovative pharmaceutical companies, from regulators like the FDA to pharmaceutical companies, from CRO giants to founders of start-ups.
    : Gathering is a fire, scattered with stars! The MacArthur Foundation has announced the winners of the 2020 MacArthur Fellows Award, just days after four biologists were named.
    21 outstanding people have been awarded this year, including four scientists working in the life sciences.
    : Creating works of art that inspire and inspire us.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.